1. Heidi Lasher
  2. Annonces
  3. jeudi 30 mars 2017

PATH is pleased to present “Building Next Generation Immunization Supply Chains” a special edition of Vaccine journal which brings together evidence from global experts in 31 articles representing decades of work by country governments, implementing partners, and donors to improve immunization supply chains (iSC). The articles address the impact of iSC on vaccine coverage, current challenges, and successful pilots, promising ideas and innovations, and upstream solutions that can all help mitigate these challenges. Guest editors of the journal include Benjamin Schreiber (UNICEF), Bruce Lee (Johns Hopkins Bloomberg School of Public Health), and Raja Rao (Bill & Melinda Gates Foundation).

Compiled in this way for the first time, the evidence presented in the special edition will serve as a ready reference for supply chain practitioners, underscore the importance of iSC performance for all partners in vaccine discovery and delivery, and help elevate performance improvements onto the priority agendas of global, regional, and country level stakeholders.

To support the special edition and to tell the story of how strong immunization supply chains help vaccinate more kids and save more lives, PATH developed an accompanying digital feature: Connecting the Dots: How to get vaccines to more kids. The feature is designed with animated illustrations and social media friendly content to help build awareness for this important aspect of immunization programs. We invite you to check it out and share it with your networks using the social media toolkit below.

What can you do?

Learn More

· Visit Connecting the Dots: How to get vaccines to more kids

· Read Building Next Generation Immunization Supply Chains

Share with your networks

· Easy retweet: https://twitter.com/PATHtweets/status/847508916422496256

· Share on Facebook: https://www.facebook.com/PATHglobalhealth/posts/10154185969685059

· Social Media Toolkit: http://pathisc.nptoolkit.org/



Il n’y a encore aucune réponse faite pour cette discussion.
Cependant, vous n'êtes pas autorisé à répondre à ce message.